Differential efficiencies to neutralize the novel mutants B.1.1.7 and 501Y.V2 by collected sera from convalescent COVID-19 patients and RBD nanoparticle-vaccinated rhesus macaques.
Título
Differential efficiencies to neutralize the novel mutants B.1.1.7 and 501Y.V2 by collected sera from convalescent COVID-19 patients and RBD nanoparticle-vaccinated rhesus macaques.
Autor
Hui Zhang, Rong Li, Xiancai Ma, Jieyi Deng, Qier Chen, Weiwei Liu, Zhilin Peng, Yidan Qiao, Yingtong Lin, Xin He
Fecha
2021
Identificador
10.1038/s41423-021-00641-8
Fuente
Cellular & molecular immunology
Colección
Citación
Hui Zhang, Rong Li, Xiancai Ma, Jieyi Deng, Qier Chen, Weiwei Liu, Zhilin Peng, Yidan Qiao, Yingtong Lin, Xin He, “Differential efficiencies to neutralize the novel mutants B.1.1.7 and 501Y.V2 by collected sera from convalescent COVID-19 patients and RBD nanoparticle-vaccinated rhesus macaques.,” SOCICT Open, consulta 18 de abril de 2026, https://www.socictopen.socict.org/items/show/8747.
Position: 16987 (18 views)